4//SEC Filing
MUTO FREDERICK T 4
Accession 0000874015-22-000124
CIK 0000874015other
Filed
Jul 5, 8:00 PM ET
Accepted
Jul 6, 5:25 PM ET
Size
12.7 KB
Accession
0000874015-22-000124
Insider Transaction Report
Form 4
MUTO FREDERICK T
Director
Transactions
- Exercise/Conversion
Non-Qualified Stock Option (right to buy)
2022-07-01−11,250→ 0 totalExercise: $12.94From: 2013-07-02Exp: 2022-07-01→ Common Stock (11,250 underlying) - Award
Restricted Stock Unit
2022-07-01+5,333→ 15,108 totalExercise: $0.00→ Common Stock (5,333 underlying) - Award
Non-Qualified Stock Option (right to buy)
2022-07-01+12,000→ 12,000 totalExercise: $38.06From: 2023-07-01Exp: 2032-06-30→ Common Stock (12,000 underlying) - Exercise/Conversion
Common Stock
2022-07-01$12.94/sh+11,250$145,575→ 51,599 total
Holdings
- 1,500(indirect: By Cooley Pen Plan)
Common Stock
Footnotes (4)
- [F1]Acquired as a result of exercising a stock option that was scheduled to expire on 7/1/2022.
- [F2]Grant on July 1, 2022 to reporting person of stock options under the Amended and Restated Ionis Pharmaceuticals, Inc. 2002 Non-Employee Directors' Stock Option Plan. 100% of the shares subject to the option vest and become exercisable on either the first anniversary of the date of grant or the next regularly scheduled annual meeting of stockholders of the Company, whichever occurs earlier. The option is exercisable to 0 shares on July 1, 2022.
- [F3]Each Restricted Stock Unit represents a contingent right to receive one share of Ionis common stock, or its equivalent cash value.
- [F4]Grant on July 1, 2022 to reporting person of Restricted Stock Unit award under the Amended and Restated Ionis Pharmaceuticals, Inc. 2002 Non-Employee Directors' Stock Option Plan. These Restricted Stock Units vest 100% on either the first anniversary of the date of grant or the next regularly scheduled annual meeting of stockholders of the Company, whichever occurs earlier, and will be delivered to the reporting person on the July 15th following the vesting date. The Restricted Stock Unit is vested as to 0 shares on July 1, 2022.
Documents
Issuer
IONIS PHARMACEUTICALS INC
CIK 0000874015
Entity typeother
IncorporatedDE
Related Parties
1- filerCIK 0001181560
Filing Metadata
- Form type
- 4
- Filed
- Jul 5, 8:00 PM ET
- Accepted
- Jul 6, 5:25 PM ET
- Size
- 12.7 KB